Researcher profile
Iain S. McGregor
Affiliations
Organizations
Cooperative Trials Group for Neuro-Oncologyauthorship · AUHunter New England Local Health Districtauthorship · AUIo Therapeutics (United States)authorship · USNational Institute of Integrative Medicineauthorship · AUSwinburne University of Technologyauthorship · AUThe University of Sydneyauthorship · AUUNSW Sydneyauthorship · AU
Public evidence
32 connected articles
A sleepy cannabis constituent: cannabinol and its active metabolite influence sleep architecture in rats.2025 · Europe PMCUse of Medicinal Cannabis for Epilepsy in the Australian Community 2023-2024: A Cross-Sectional Survey.2025 · Europe PMCFactors associated with cannabis use disorder among Australians using prescribed and illicitly-sourced medical cannabis.2025 · Europe PMCEvaluating possible 'next day' impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial.2024 · Europe PMCMedical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022-2023 (CAMS-22).2024 · Europe PMCA cross-sectional survey exploring the knowledge, experiences and attitudes of Australian pharmacists toward medicinal cannabis.2023 · Europe PMCMedicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing.2023 · PubMed Central Open AccessDriving-related behaviors, attitudes, and perceptions among Australian medical cannabis users: results from the CAMS 20 survey.2023 · PubMed Central Open AccessThe "Next Day" Effects of Cannabis Use: A Systematic Review.2023 · Europe PMCA nutraceutical product, extracted from Cannabis sativa, modulates voltage-gated sodium channel function.2022 · Europe PMCMedical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20).2022 · Europe PMCKnowledge, experiences, and attitudes of Australian General Practitioners towards medicinal cannabis: a 2021-2022 survey.2022 · PubMed Central Open AccessMedicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years.2022 · PubMed Central Open AccessThe safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence.2022 · PubMed Central Open AccessCorrelates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder.2022 · Europe PMCOlivetolic acid, a cannabinoid precursor in Cannabis sativa, but not CBGA methyl ester exhibits a modest anticonvulsant effect in a mouse model of Dravet syndrome.2022 · PubMed Central Open AccessCannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis.2022 · Europe PMCThe use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients.2021 · Europe PMCMedicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences, and Current Use in Australian Patients2020 · PubMed Central Open AccessAttitudes and Knowledge of Australian Gastroenterologists Around the Use of Medicinal Cannabis for Inflammatory Bowel Disease2020 · PubMed Central Open AccessTerpenoids Commonly Found in <i>Cannabis sativa</i> Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels.2020 · Europe PMCMedical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18).2020 · PubMed Central Open AccessAbsence of Entourage: Terpenoids Commonly Found in <i>Cannabis sativa</i> Do Not Modulate the Functional Activity of Δ<sup>9</sup>-THC at Human CB<sub>1</sub> and CB<sub>2</sub> Receptors.2019 · Europe PMCCannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition.2019 · Europe PMCDetection of Δ<sup>9</sup> THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point-of-collection testing devices.2019 · Europe PMCOral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV).2018 · Europe PMCComposition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community.2018 · Europe PMCAuthor Correction: Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community.2018 · PubMed Central Open AccessRandomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol.2018 · Europe PMCNovel molecular changes induced by Nrg1 hypomorphism and Nrg1-cannabinoid interaction in adolescence: a hippocampal proteomic study in mice2013 · PubMed Central Open Access
Registered research
Connected studies
Matched by exact identifiers only. Profile data: Corpus/OpenAlex.